Editorial: Cell-Matrix Mechanobiology in Diseases and Development

por Shokeen, Bhumika, Purbey, Prabhat K., Meli, Vijaykumar S.
Publicado 2022

Mechanistic insight into the protective and pathogenic immune-responses against SARS-CoV-2

por Purbey, Prabhat K., Roy, Koushik, Gupta, Sandeep, Paul, Manash K.
Publicado 2023

pC6-2/caspase-6 system to purify glutathione-S-transferase-free recombinant fusion proteins expressed in Escherichia coli

por Purbey, Prabhat Kumar, Jayakumar, P Cyril, Patole, Milind S, Galande, Sanjeev
Publicado 2006

COVID-19 and gut immunomodulation

por Roy, Koushik, Agarwal, Sidra, Banerjee, Rajib, Paul, Manash K, Purbey, Prabhat K
Publicado 2021

PDZ domain-mediated dimerization and homeodomain-directed specificity are required for high-affinity DNA binding by SATB1

por Purbey, Prabhat Kumar, Singh, Sunita, Kumar, P. Pavan, Mehta, Sameet, Ganesh, K. N., Mitra, Debashis, Galande, Sanjeev
Publicado 2008

Global Regulator SATB1 Recruits β-Catenin and Regulates T(H)2 Differentiation in Wnt-Dependent Manner

por Notani, Dimple, Gottimukkala, Kamalvishnu P., Jayani, Ranveer S., Limaye, Amita S., Damle, Madhujit V., Mehta, Sameet, Purbey, Prabhat Kumar, Joseph, Jomon, Galande, Sanjeev
Publicado 2010

Opposing roles of Toll-like receptor and cytosolic DNA-STING signaling pathways for Staphylococcus aureus cutaneous host defense

por Scumpia, Philip O., Botten, Giovanni A., Norman, Joshua S., Kelly-Scumpia, Kindra M., Spreafico, Roberto, Ruccia, Amber R., Purbey, Prabhat K., Thomas, Brandon J., Modlin, Robert L., Smale, Stephen T.
Publicado 2017

4-(Nitrophenylsulfonyl)piperazines mitigate radiation damage to multiple tissues

por Micewicz, Ewa D., Kim, Kwanghee, Iwamoto, Keisuke S., Ratikan, Josephine A., Cheng, Genhong, Boxx, Gayle M., Damoiseaux, Robert D., Whitelegge, Julian P., Ruchala, Piotr, Nguyen, Christine, Purbey, Prabhat, Loo, Joseph, Deng, Gang, Jung, Michael E., Sayre, James W., Norris, Andrew J., Schaue, Dörthe, McBride, William H.
Publicado 2017

Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication

por Garcia, Gustavo, Sharma, Arun, Ramaiah, Arunachalam, Sen, Chandani, Purkayastha, Arunima, Kohn, Donald B., Parcells, Mark S., Beck, Sebastian, Kim, Heeyoung, Bakowski, Malina A., Kirkpatrick, Melanie G., Riva, Laura, Wolff, Karen C., Han, Brandon, Yuen, Constance, Ulmert, David, Purbey, Prabhat K., Scumpia, Phillip, Beutler, Nathan, Rogers, Thomas F., Chatterjee, Arnab K., Gabriel, Gülsah, Bartenschlager, Ralf, Gomperts, Brigitte, Svendsen, Clive N., Betz, Ulrich A.K., Damoiseaux, Robert D., Arumugaswami, Vaithilingaraja
Publicado 2021